338 Effects of pembrolizumab on the tumor microenvironment (TME) after one presurgery treatment cycle in patients with triple-negative breast cancer (TNBC): phase 1b KEYNOTE-173 study
oleh: Sung-Bae Kim, Jennifer Yearley, Rebecca Dent, Javier Cortes, Lingkang Huang, Yeon Hee Park, Theodoros Foukakis, Eva Muñoz-Couselo, Yuan Sun, Peter Schmid, Joohyuk Sohn, Seock-Ah Im, Esther Holgado, Sherko Kümmel, Petar Jelinic, Vassiliki Karantza
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.